A Phase III, Multi-center, Open-label, Randomized Study to Assess the Efficacy and Safety of Org 37462 Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for IVF or ICSI, Using a Long Protocol of Triptorelin as a Reference Treatment.

Trial Profile

A Phase III, Multi-center, Open-label, Randomized Study to Assess the Efficacy and Safety of Org 37462 Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for IVF or ICSI, Using a Long Protocol of Triptorelin as a Reference Treatment.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Dec 2014

At a glance

  • Drugs Ganirelix (Primary) ; Chorionic gonadotropin; Recombinant follicle-stimulating hormone; Triptorelin
  • Indications Infertility
  • Focus Therapeutic Use
  • Sponsors Organon
  • Most Recent Events

    • 27 Jan 2010 Actual end date changed from Nov 2008 to Dec 2008 as reported by ClinicalTrials.gov.
    • 25 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 26 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top